(SCHG) Schwab U.S. Large-Cap Growth - Ratings and Ratios
Stocks, Growth, Large-Cap, Technology, Healthcare
Dividends
| Dividend Yield | 0.26% |
| Yield on Cost 5y | 0.56% |
| Yield CAGR 5y | -15.26% |
| Payout Consistency | 90.6% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 17.7% |
| Value at Risk 5%th | 30.6% |
| Relative Tail Risk | 4.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | -1.36 |
| CAGR/Max DD | 1.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.350 |
| Beta | 1.173 |
| Beta Downside | 1.151 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.39% |
| Mean DD | 2.83% |
| Median DD | 1.50% |
Description: SCHG Schwab U.S. Large-Cap Growth December 03, 2025
Schwab’s U.S. Large-Cap Growth ETF (ticker SCHG) tracks the Dow Jones U.S. Large-Cap Growth Total Stock Market Index, which selects the 750 largest U.S. companies classified as “growth” based on metrics such as earnings-growth rates and price-to-sales ratios. The fund’s mandate is to replicate the index’s performance by holding the constituent stocks in proportion to their market-cap weights.
As of the most recent filing (Q3 2024), SCHG carries an expense ratio of 0.04 % and manages roughly $22 billion in assets, making it one of the lowest-cost large-cap growth vehicles. Its top ten holdings are dominated by technology and consumer discretionary firms (e.g., Apple, Microsoft, Amazon), which together account for about 45 % of the portfolio. The ETF’s performance is highly sensitive to macro-level drivers such as the Federal Reserve’s interest-rate policy (which influences growth-stock valuations) and corporate earnings growth in the tech sector, which historically contributes over 30 % of the index’s return variance.
For a deeper dive into SCHG’s risk-adjusted metrics, sector exposure trends, and how its valuation compares to peers, you might explore the ValueRay platform for a data-rich, side-by-side analysis.
What is the price of SCHG shares?
Over the past week, the price has changed by -1.39%, over one month by -1.42%, over three months by +3.60% and over the past year by +13.80%.
Is SCHG a buy, sell or hold?
What are the forecasts/targets for the SCHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 39.9 | 22.8% |
SCHG Fundamental Data Overview December 03, 2025
Beta = 1.1
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 52.61b USD (52.61b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 52.61b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 52.61b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.34% (E(52.61b)/V(52.61b) * Re(10.34%) + (debt-free company))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for SCHG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle